GERN Q1 2024 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$304,000+1347.6% YoY

Gross Profit

$304,000100.0% margin

Operating Income

-$56M-18465.1% margin

Net Income

-$55M-18220.4% margin

EPS (Diluted)

$-0.09

QoQ Revenue Growth

+1221.7%

Cash Flow

Operating Cash Flow

-$62M

Free Cash Flow

-$63M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$482M

Total Liabilities

$137M

Stockholders' Equity

$345M

Cash & Equivalents

$190M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$304,000	$21,000	+1347.6%
Gross Profit	$304,000	$21,000	+1347.6%
Operating Income	-$56M	-$40M	-40.0%
Net Income	-$55M	-$38M	-45.3%